Orthopediatrics (KIDS) Cash from Discontinued Operations (2019)

Orthopediatrics (KIDS) recorded quarterly Cash from Discontinued Operations of 734000.0 in Q4 2019, down 435.16% quarter-over-quarter from 219000.0 in Q3 2019.

Orthopediatrics (KIDS) Cash from Discontinued Operations (2019) Analysis & Trends

Orthopediatrics' Cash from Discontinued Operations history runs 1 years deep, the most recent figure standing at 734000.0 for Q4 2019.

  • In Q4 2019, Cash from Discontinued Operations changed N/A year-over-year to 734000.0; the TTM figure through Dec 2020 stood at 515000.0 (changed 0.0% YoY), while the FY2019 annual figure was 144000.0, changed N/A from the prior year.
  • Cash from Discontinued Operations was 734000.0 for Q4 2019 at Orthopediatrics, down from 219000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 219000.0 in Q3 2019 to a low of 734000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Orthopediatrics 424.91 Mn 376.10 Mn 43.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -734,000.00
Dec 31, 2019 -734,000.00
Sep 30, 2019 219,000.00
Sep 30, 2019 219,000.00